RFE-011

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRFE-011
Drug Alias Namesomatostatin analogs (RFE Pharma)RFE-011
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionSomatostatin receptor 2 agonists
TargetsSomatostatin receptor 2
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis AgSomatocor Pharmaceuticals IncRfe Pharma
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A